Seeing Is Believing
Currently out of the existing stock ratings of Andrew Baum, 26 are a HOLD (35.62%), 45 are a BUY (61.64%), 2 are a SELL (2.74%).
Analyst Andrew Baum, carries an average stock price target met ratio of 57.25% that have a potential upside of 20.21% achieved within 386 days. Previously, Andrew Baum worked at CITI.
Andrew Baum’s has documented 149 price targets and ratings displayed on 11 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on MRK, Merck mpany at 05-Feb-2025.
Analyst best performing recommendations are on LLY (ELI LILLY AND COMPANY).
The best stock recommendation documented was for BMY (BRISTOL-MYERS SQUIBB COMPANY) at 10/25/2024. The price target of $55 was fulfilled within 6 days with a profit of $3.65 (7.11%) receiving and performance score of 11.85.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$240
$53.04 (28.37%)
$210
1 months ago
(05-Mar-2025)
7/8 (87.5%)
$28.46 (13.45%)
474
Hold
$223
$36.04 (19.28%)
$191
1 months 1 days ago
(04-Mar-2025)
3/4 (75%)
$15.71 (7.58%)
443
Buy
$214
$27.04 (14.46%)
$221
2 months 2 days ago
(03-Feb-2025)
23/24 (95.83%)
$23.86 (12.55%)
431
Buy
$217
$30.04 (16.07%)
$211
2 months 2 days ago
(03-Feb-2025)
2/3 (66.67%)
$26.86 (14.13%)
103
Buy
$220
$33.04 (17.67%)
$195
2 months 2 days ago
(03-Feb-2025)
11/12 (91.67%)
$29.86 (15.70%)
342
Which stock is Andrew Baum is most bullish on?
Which stock is Andrew Baum is most reserved on?
What Year was the first public recommendation made by Andrew Baum?